NCT04526860View on ClinicalTrials.gov

Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions

Obesity, Infant

Interventions

OTHER

Calibration of infant breast milk and formula milk intake

We will calibrate (reduce) the pumped breast milk or formula intake of infants of overweight and obese mothers who exceed 2 standard deviations of normal WHO weight standards, in order to prevent infant obesity and subsequent childhood obesity.

Trial Locations (1)

04025-002

Breastfeeding Center Ana Abrao, Federal of São Paulo University, Brazil, São Paulo

All Listed Sponsors

collaborator

Federal University of São Paulo

OTHER

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT04526860 - Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity | Biotech Hunter | Biotech Hunter